Lighthouse Investment Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,000
Closed -$1.78M 957
2025
Q4
$1.78M Buy
+35,000
New +$1.79M 0.05% 374
2025
Q1
Sell
-38,500
Closed -$3.31M 592
2024
Q4
$3.31M Buy
+38,500
New +$4.16M 0.11% 221
2024
Q3
Sell
-25,619
Closed -$3.42M 519
2024
Q2
$3.66M Buy
+25,619
New +$3.39M 0.15% 168

Other funds holding NVO

Lighthouse Investment Partners's NVO Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 35,000 shares — an estimated $1.78M sold.

Lighthouse Investment Partners first reported a position in NVO in Q2 2024 and held it in 3 quarters. The position peaked at $3.66M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 35,000 Novo Nordisk shares in Q1 2026, an estimated $1.78M.
  • Lighthouse Investment Partners first reported a position in Novo Nordisk in Q2 2024 and held it in 3 quarters.
  • Lighthouse Investment Partners's Novo Nordisk position peaked at $3.66M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.